Mon panier

Human SSTR2 Full Length Protein (VLP)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
SS2-H5216-20ug
$620.00
SS2-H5216-100ug
$1235.00
SS2-H5216-500ug
$4305.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    Smstr2, Somatostatin R2, somatostatin receptor 2, somatostatin receptor type 2, SomatostatinR2, SRIF-1, SS2R, SS-2-R, SS2-R, SST2, SSTR2

  • Source

    Human SSTR2 Full Length Protein-VLP (SS2-H5216) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ile 369 (Accession # P30874-1).

    Predicted N-terminus: Asp

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SEC-HPLC.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SEC-HPLC

    SSTR2 SEC-HPLC

    The purity of Human SSTR2 Full Length Protein-VLP (Cat. No. SS2-H5216) was greater than 95% as determined by SEC-HPLC.

  • Bioactivity-ELISA

     SSTR2 ELISA

    Immobilized Human SSTR2 Full Length Protein-VLP (Cat. No. SS2-H5216) at 5 μg/mL (100 μL/well) can bind Anti-SSTR2 Antibody, Human IgG1 with a linear range of 0.3-5 ng/mL (QC tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Introduction de fond

Somatostatin Receptor Type 2, the predominant subtype mediating inhibition of hormone secretion and cell proliferation. It is the primary target for long-acting somatostatin analogs (octreotide, lanreotide) in acromegaly and neuroendocrine tumors. Radiolabeled SSTR2 ligands (PRRT) enable targeted theranostic applications.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Somatostatin receptor 2

  • Catégorie:

  • Nombre de médicaments répertoriés:

    7 Détails

  • Nombre de médicaments cliniques:

    29 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte